32 results
UPLOAD
PCSA
Processa Pharmaceuticals Inc
24 Oct 18
Letter from SEC
12:00am
,
Division of
Corporation Finance
Office of Healthcare
& Insurance
cc: Neda A. Sharifi
8-K
PCSA
Processa Pharmaceuticals Inc
12 Oct 17
Entry into a Material Definitive Agreement
12:00am
reimbursements for healthcare expenditures play an important role for all healthcare providers, including physicians and pharmaceutical companies … a material adverse effect on our business, financial condition and results of operations.
Legislative or regulatory reform of the healthcare system may
CORRESP
PCSA
Processa Pharmaceuticals Inc
30 Oct 18
Correspondence with SEC
12:00am
Commission
Division of Corporation Finance
Office of Healthcare & Insurance
Washington, D.C. 20549
Re:
Processa Pharmaceuticals, Inc.
Amendment No. 2
UPLOAD
PCSA
Processa Pharmaceuticals Inc
24 Oct 18
Letter from SEC
12:00am
of
Healthcare & Insurance
October 24, 2018 Page 2
cc: Neda Sharifi
FirstName LastName
8-K
PCSA
Processa Pharmaceuticals Inc
17 Mar 22
Regulation FD Disclosure
8:30am
with analysts and investors at the Oppenheimer 32nd Annual Healthcare Conference. During these virtual meetings, Processa’s presentation will be uploaded
8-K
EX-99.1
hsr7bdgc
20 Aug 20
Entry into a Material Definitive Agreement
9:30am
8-K
EX-99.1
2zpana
5 Mar 20
Processa Pharmaceuticals Announces Formation of Its Medical and Scientific Advisory Board
9:30am
UPLOAD
5r8d1
1 Oct 18
Letter from SEC
12:00am
424B4
8kf 2orbrq
5 Oct 20
Prospectus supplement with pricing info
4:16pm